These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 334362)
61. Incidence of Head and Neck Lymphoma in Guilan Province, Iran. Basirat M; Rabiei M; Bashardoust N Asian Pac J Cancer Prev; 2016; 17(S3):1-4. PubMed ID: 27165198 [TBL] [Abstract][Full Text] [Related]
62. Mast cell reactivity in lymphoma: a preliminary communication. Sharma VK; Agrawal A; Pratap VK; Nagar AM; Mehrotra ML Indian J Cancer; 1992 Jun; 29(2):61-5. PubMed ID: 1473834 [TBL] [Abstract][Full Text] [Related]
63. Treatment of grey zone lymphomas. Fisher RI Ann Oncol; 1998; 9 Suppl 5():S121-3. PubMed ID: 9926250 [TBL] [Abstract][Full Text] [Related]
68. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies. Jaffe ES; Zarate-Osorno A; Medeiros LJ Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852 [TBL] [Abstract][Full Text] [Related]
69. Histopathology of Hodgkin's lymphoma. Eberle FC; Mani H; Jaffe ES Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308 [TBL] [Abstract][Full Text] [Related]
70. Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations. Come SE; Jaffe ES; Andersen JC; Mann RB; Johnson BL; DeVita VT; Young RC Am J Med; 1980 Nov; 69(5):667-74. PubMed ID: 7001897 [TBL] [Abstract][Full Text] [Related]
71. Involvement of the central nervous system in non-Hodgkin's lymphoma. Law IP; Dick FR; Blom J; Bergevin PR Cancer; 1975 Jul; 36(1):225-31. PubMed ID: 1106832 [TBL] [Abstract][Full Text] [Related]
72. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma. Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368 [TBL] [Abstract][Full Text] [Related]
73. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms]. Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877 [TBL] [Abstract][Full Text] [Related]
74. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)]. Krivolapov IuA Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131 [TBL] [Abstract][Full Text] [Related]
75. Fibrosis in Hodgkin and non-Hodgkin lymphomas. Tataroglu C; Sarioglu S; Kargi A; Ozkal S; Aydin O Pathol Res Pract; 2007; 203(10):725-30. PubMed ID: 17804176 [TBL] [Abstract][Full Text] [Related]
76. Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study. Harrington DS; Ye YL; Weisenburger DD; Armitage JO; Pierson J; Bast M; Purtilo DT Hum Pathol; 1987 Sep; 18(9):924-8. PubMed ID: 3497862 [TBL] [Abstract][Full Text] [Related]
77. Non-Hodgkin's lymphoma in northern India. A retrospective analysis of 238 cases. Garg A; Dawar R; Agarwal V; Rustagi RK; Kochupillai V Cancer; 1985 Aug; 56(4):972-7. PubMed ID: 4016691 [TBL] [Abstract][Full Text] [Related]
78. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease. Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684 [TBL] [Abstract][Full Text] [Related]
79. [A clinical analysis of 21 cases of adrenal non-Hodgkin's lymphoma]. Bu N; Wu H; Yao J; Zhang J; Gao Y; Guo X Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):22-6. PubMed ID: 25877141 [TBL] [Abstract][Full Text] [Related]
80. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma. Kamel OW; Gelb AB; Shibuya RB; Warnke RA Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]